Literature DB >> 25457367

GP5 expression in Marc-145 cells inhibits porcine reproductive and respiratory syndrome virus infection by inducing beta interferon activity.

Jiming Gao1, Pengchao Ji2, Maodong Zhang3, Xiangpeng Wang4, Na Li5, Chengbao Wang6, Shuqi Xiao7, Yang Mu8, Qin Zhao9, Taofeng Du10, Yani Sun11, Julian A Hiscox12, Gaiping Zhang13, En-Min Zhou14.   

Abstract

The major neutralizing epitope of porcine reproductive and respiratory syndrome virus (PRRSV) is mainly located on virus glycoprotein 5 (GP5). Immunization with exogenous GP5 or exposure to native GP5 by means of DNA immunization can provide some degree of immune protection to PRRSV infection in pigs. However, during PRRSV infection in pigs, the production of neutralization antibodies induced by GP5 is delayed or suppressed. This suggests that the synthesis of GP5 is late than some PRRSV proteins or other PRRSV proteins interfering with the function of GP5 in inducing host responses during virus infection. Here, to exclude the impacts of the other PRRSV proteins and determine the role of GP5 in the replication of PRRSV in vitro, a Marc-145 cell line stably expressing GP5 (Marc-145-GP5(Flag)) was constructed. Cell proliferation and cell apoptosis measurements indicated that the expression of GP5 in Marc-145 cells did not disturb the cells' viability. Following infection with different PRRSV strains PRRSV replication in Marc-145-GP5(Flag) cells was inhibited significantly. Type I interferon assay results showed that beta interferon (IFN-β) in the Marc-145-GP5(Flag) cells were increased at mRNA and protein levels. When siRNA was introduced into the cells to knock down IFN-β mRNA, PRRSV infectivity of these cells was recovered. These data suggest that early GP5 expression is not favorable for further infection by PRRSV, because it not only stimulates production of neutralization antibodies in pigs, but also induces IFN-β production in host cells. Therefore, GP5 is an important protein in the induction of self-protection responses from the host.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell apoptosis; Cell viability; GP5; Interferon; PRRSV

Mesh:

Substances:

Year:  2014        PMID: 25457367     DOI: 10.1016/j.vetmic.2014.09.030

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  Identification of MYH9 Key Domain Involved in the Entry of PRRSV Into Permissive Cells.

Authors:  Liangliang Li; Weiyao Sun; Qifan Hu; Tongtong Wang; Guang Zhu; Qin Zhao; En-Min Zhou
Journal:  Front Microbiol       Date:  2022-05-25       Impact factor: 6.064

2.  Analysis of genetic variation of porcine reproductive and respiratory syndrome virus (PRRSV) isolates in Central China.

Authors:  Can Liu; Yibao Ning; Binrui Xu; Wenzhi Gong; Dongdong Zhang
Journal:  J Vet Med Sci       Date:  2016-01-15       Impact factor: 1.267

3.  Monkey Viperin Restricts Porcine Reproductive and Respiratory Syndrome Virus Replication.

Authors:  Jianyu Fang; Haiyan Wang; Juan Bai; Qiaoya Zhang; Yufeng Li; Fei Liu; Ping Jiang
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

Review 4.  Key Gaps in the Knowledge of the Porcine Respiratory Reproductive Syndrome Virus (PRRSV).

Authors:  Sergio Montaner-Tarbes; Hernando A Del Portillo; María Montoya; Lorenzo Fraile
Journal:  Front Vet Sci       Date:  2019-02-20

5.  MYH9 is an Essential Factor for Porcine Reproductive and Respiratory Syndrome Virus Infection.

Authors:  Jiming Gao; Shuqi Xiao; Yihong Xiao; Xiangpeng Wang; Chong Zhang; Qin Zhao; Yuchen Nan; Baicheng Huang; Hongliang Liu; Ningning Liu; Junhua Lv; Taofeng Du; Yani Sun; Yang Mu; Gang Wang; Shahid Faraz Syed; Gaiping Zhang; Julian A Hiscox; Ian Goodfellow; En-Min Zhou
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

6.  The Immunological Regulation Roles of Porcine β-1, 4 Galactosyltransferase V (B4GALT5) in PRRSV Infection.

Authors:  Lei Zhang; Jie Ren; Peidian Shi; Dong Lu; Chengxue Zhao; Yanxin Su; Lilin Zhang; Jinhai Huang
Journal:  Front Cell Infect Microbiol       Date:  2018-03-01       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.